Annual EBIT:
-$50.41M-$4.34M(-9.42%)Summary
- As of today, AKBA annual earnings before interest & taxes is -$50.41 million, with the most recent change of -$4.34 million (-9.42%) on December 31, 2024.
- During the last 3 years, AKBA annual EBIT has risen by +$214.09 million (+80.94%).
- AKBA annual EBIT is now -491.53% below its all-time high of -$8.52 million, reached on December 31, 2012.
Performance
AKBA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$14.09M+$575.00K(+4.25%)Summary
- As of today, AKBA quarterly earnings before interest & taxes is $14.09 million, with the most recent change of +$575.00 thousand (+4.25%) on June 1, 2025.
- Over the past year, AKBA quarterly EBIT has increased by +$22.81 million (+261.48%).
- AKBA quarterly EBIT is now -71.01% below its all-time high of $48.61 million, reached on June 30, 2022.
Performance
AKBA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$791.00K+$22.81M(+103.59%)Summary
- As of today, AKBA TTM earnings before interest & taxes is $791.00 thousand, with the most recent change of +$22.81 million (+103.59%) on June 1, 2025.
- Over the past year, AKBA TTM EBIT has increased by +$35.89 million (+102.25%).
- AKBA TTM EBIT is now at all-time high.
Performance
AKBA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AKBA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -9.4% | +261.5% | +102.3% |
| 3Y3 Years | +80.9% | -71.0% | +100.6% |
| 5Y5 Years | +82.4% | +124.2% | +100.3% |
AKBA EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -9.4% | +80.9% | at high | +128.1% | at high | +100.6% |
| 5Y | 5-Year | -9.4% | +82.4% | -71.0% | +116.5% | at high | +100.3% |
| All-Time | All-Time | -491.5% | +82.4% | -71.0% | +114.8% | at high | +100.3% |
AKBA EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $14.09M(+4.3%) | $791.00K(+103.6%) |
| Mar 2025 | - | $13.51M(+194.5%) | -$22.02M(+56.3%) |
| Dec 2024 | -$50.41M(-9.4%) | -$14.31M(-14.4%) | -$50.41M(-45.1%) |
| Sep 2024 | - | -$12.51M(-43.3%) | -$34.73M(+1.0%) |
| Jun 2024 | - | -$8.72M(+41.4%) | -$35.10M(+1.0%) |
| Mar 2024 | - | -$14.88M(-1182.8%) | -$35.46M(+23.0%) |
| Dec 2023 | -$46.08M(+28.9%) | $1.37M(+110.7%) | -$46.07M(+18.5%) |
| Sep 2023 | - | -$12.87M(-41.6%) | -$56.56M(+39.8%) |
| Jun 2023 | - | -$9.09M(+64.3%) | -$93.92M(-159.3%) |
| Mar 2023 | - | -$25.49M(-179.7%) | -$36.23M(+47.7%) |
| Dec 2022 | -$64.85M(+75.5%) | -$9.12M(+81.9%) | -$69.23M(+44.8%) |
| Sep 2022 | - | -$50.23M(-203.3%) | -$125.45M(-1.1%) |
| Jun 2022 | - | $48.61M(+183.1%) | -$124.11M(+50.8%) |
| Mar 2022 | - | -$58.49M(+10.5%) | -$252.06M(+2.5%) |
| Dec 2021 | -$264.50M(-1.4%) | -$65.34M(-33.7%) | -$258.50M(+7.2%) |
| Sep 2021 | - | -$48.89M(+38.4%) | -$278.57M(+3.2%) |
| Jun 2021 | - | -$79.34M(-22.2%) | -$287.77M(-7.9%) |
| Mar 2021 | - | -$64.94M(+24.0%) | -$266.73M(-2.2%) |
| Dec 2020 | -$260.92M(+8.9%) | -$85.40M(-47.0%) | -$260.92M(+3.5%) |
| Sep 2020 | - | -$58.09M(+0.3%) | -$270.40M(-0.8%) |
| Jun 2020 | - | -$58.29M(+1.4%) | -$268.21M(+0.5%) |
| Mar 2020 | - | -$59.13M(+37.7%) | -$269.44M(+5.9%) |
| Dec 2019 | -$286.29M(-84.6%) | -$94.89M(-69.7%) | -$286.29M(-1.7%) |
| Sep 2019 | - | -$55.91M(+6.1%) | -$281.53M(-11.1%) |
| Jun 2019 | - | -$59.52M(+21.6%) | -$253.47M(-10.4%) |
| Mar 2019 | - | -$75.97M(+15.7%) | -$229.61M(-28.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$155.06M(-102.2%) | -$90.14M(-223.7%) | -$178.14M(-142.7%) |
| Sep 2018 | - | -$27.84M(+21.9%) | -$73.39M(-5.3%) |
| Jun 2018 | - | -$35.66M(-45.6%) | -$69.73M(-24.1%) |
| Mar 2018 | - | -$24.50M(-267.7%) | -$56.20M(+26.7%) |
| Dec 2017 | -$76.67M(+43.6%) | $14.61M(+160.4%) | -$76.67M(+40.7%) |
| Sep 2017 | - | -$24.18M(-9.2%) | -$129.33M(+8.5%) |
| Jun 2017 | - | -$22.14M(+50.8%) | -$141.33M(+9.0%) |
| Mar 2017 | - | -$44.97M(-18.2%) | -$155.39M(-14.2%) |
| Dec 2016 | -$135.96M(-122.1%) | -$38.04M(-5.1%) | -$136.06M(-15.3%) |
| Sep 2016 | - | -$36.18M(+0.0%) | -$118.01M(-16.3%) |
| Jun 2016 | - | -$36.19M(-41.1%) | -$101.43M(-33.4%) |
| Mar 2016 | - | -$25.65M(-28.3%) | -$76.03M(-24.2%) |
| Dec 2015 | -$61.21M(-63.2%) | -$20.00M(-2.0%) | -$61.21M(-18.1%) |
| Sep 2015 | - | -$19.61M(-81.7%) | -$51.83M(-24.0%) |
| Jun 2015 | - | -$10.79M(+0.3%) | -$41.80M(-7.6%) |
| Mar 2015 | - | -$10.82M(-2.0%) | -$38.85M(-3.3%) |
| Dec 2014 | -$37.50M(-135.3%) | -$10.61M(-10.7%) | -$37.62M(-13.3%) |
| Sep 2014 | - | -$9.58M(-22.2%) | -$33.21M(-20.1%) |
| Jun 2014 | - | -$7.84M(+18.2%) | -$27.66M(-20.6%) |
| Mar 2014 | - | -$9.59M(-54.6%) | -$22.94M(-44.0%) |
| Dec 2013 | -$15.93M(-87.0%) | -$6.20M(-53.7%) | -$15.93M(-37.4%) |
| Sep 2013 | - | -$4.03M(-29.3%) | -$11.60M(-53.3%) |
| Jun 2013 | - | -$3.12M(-21.1%) | -$7.56M(-70.3%) |
| Mar 2013 | - | -$2.58M(-38.2%) | -$4.44M(-138.2%) |
| Dec 2012 | -$8.52M(+45.2%) | - | - |
| Dec 2012 | - | -$1.86M | -$1.86M |
| Dec 2011 | -$15.54M | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual EBIT year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Akebia Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM EBIT year-on-year change?
What is Akebia Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of AKBA is -$50.41M
What is the all-time high annual EBIT for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$8.52M
What is Akebia Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, AKBA annual earnings before interest & taxes has changed by -$4.34M (-9.42%)
What is Akebia Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AKBA is $14.09M
What is the all-time high quarterly EBIT for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is $48.61M
What is Akebia Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, AKBA quarterly earnings before interest & taxes has changed by +$22.81M (+261.48%)
What is Akebia Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AKBA is $791.00K
What is the all-time high TTM EBIT for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM earnings before interest & taxes is $791.00K
What is Akebia Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, AKBA TTM earnings before interest & taxes has changed by +$35.89M (+102.25%)